These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1855 related items for PubMed ID: 19801360

  • 1. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK.
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [Abstract] [Full Text] [Related]

  • 2. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.
    DeFronzo RA.
    Am J Med; 2010 Mar; 123(3 Suppl):S38-48. PubMed ID: 20206731
    [Abstract] [Full Text] [Related]

  • 3. The role of incretin on diabetes mellitus.
    Sanusi H.
    Acta Med Indones; 2009 Oct; 41(4):205-12. PubMed ID: 20737753
    [Abstract] [Full Text] [Related]

  • 4. Therapies for the treatment of type 2 diabetes mellitus based on incretin action.
    Gallwitz B.
    Minerva Endocrinol; 2006 Jun; 31(2):133-47. PubMed ID: 16682937
    [Abstract] [Full Text] [Related]

  • 5. Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.
    Knop FK, Holst JJ, Vilsbøll T.
    IDrugs; 2008 Jul; 11(7):497-501. PubMed ID: 18600596
    [Abstract] [Full Text] [Related]

  • 6. Protection of pancreatic beta-cells: is it feasible?
    Bonora E.
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [Abstract] [Full Text] [Related]

  • 7. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ, Vilsbøll T, Deacon CF.
    Mol Cell Endocrinol; 2009 Jan 15; 297(1-2):127-36. PubMed ID: 18786605
    [Abstract] [Full Text] [Related]

  • 8. Incretins and other peptides in the treatment of diabetes.
    Todd JF, Bloom SR.
    Diabet Med; 2007 Mar 15; 24(3):223-32. PubMed ID: 17263764
    [Abstract] [Full Text] [Related]

  • 9. GIP: no longer the neglected incretin twin?
    Kulkarni RN.
    Sci Transl Med; 2010 Sep 15; 2(49):49ps47. PubMed ID: 20844284
    [Abstract] [Full Text] [Related]

  • 10. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK.
    Ann Pharmacother; 2007 Jan 15; 41(1):51-60. PubMed ID: 17190843
    [Abstract] [Full Text] [Related]

  • 11. Beta-cell function and mass in type 2 diabetes.
    Larsen MO.
    Dan Med Bull; 2009 Aug 15; 56(3):153-64. PubMed ID: 19728971
    [Abstract] [Full Text] [Related]

  • 12. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM.
    Am J Physiol Endocrinol Metab; 2006 Mar 15; 290(3):E550-9. PubMed ID: 16219666
    [Abstract] [Full Text] [Related]

  • 13. Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
    Ranganath LR.
    J Clin Pathol; 2008 Apr 15; 61(4):401-9. PubMed ID: 18375745
    [Abstract] [Full Text] [Related]

  • 14. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J.
    Regul Pept; 2005 Jun 15; 128(2):149-57. PubMed ID: 15780434
    [Abstract] [Full Text] [Related]

  • 15. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.
    Nauck MA.
    Am J Med; 2011 Jan 15; 124(1 Suppl):S3-18. PubMed ID: 21194578
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incretin effect: GLP-1, GIP, DPP4.
    Kazafeos K.
    Diabetes Res Clin Pract; 2011 Aug 15; 93 Suppl 1():S32-6. PubMed ID: 21864749
    [Abstract] [Full Text] [Related]

  • 18. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ.
    Diabetes; 2008 Mar 15; 57(3):678-87. PubMed ID: 18057091
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.
    Karaca M, Magnan C, Kargar C.
    Diabetes Metab; 2009 Apr 15; 35(2):77-84. PubMed ID: 19251449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 93.